- Home
- AUPH vs PRG Comparison
AUPH vs PRG Comparison
Compare AUPH & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | PRG |
|---|---|---|
| Founded | 1993 | 2020 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AUPH | PRG |
|---|---|---|
| Price | $16.65 | $38.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $17.25 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 1.2M | 556.9K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | 0.53 | ★ 1.80 |
| Revenue | $283,055,000.00 | ★ $2,409,223,000.00 |
| Revenue This Year | $17.54 | $23.77 |
| Revenue Next Year | $15.74 | $7.91 |
| P/E Ratio | $32.58 | ★ $21.22 |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $10.34 | $25.80 |
| 52 Week High | $19.25 | $47.73 |
Technical Indicators
Market Signals| Indicator | AUPH | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 59.83 | 37.20 |
| Support Level | $14.67 | $32.30 |
| Resistance Level | $19.25 | $41.14 |
| Average True Range (ATR) | 0.58 | 1.31 |
| MACD | 0.20 | -0.56 |
| Stochastic Oscillator | 65.63 | 12.90 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.